In 2002 a 23-yr-old female giant panda (Ailuropoda melanoleuca) presented with left hind limb lameness presumably due to osteoarthritis. For the next five years, arthritic episodes were managed with the nonsteroidal anti-inflammatory drug (NSAID) carprofen at 2 mg/kg p.o. s.i.d., then reduced to 1 mg/kg p.o. s.i.d. and withdrawn. Radiographs revealed osteoarthritis in various joints and lumbar spondylosis. In 2007 glucosamine and chondroitin at 1.65 g p.o. b.i.d. and a polyunsaturated fatty acid at 1 capsule p.o. s.i.d. By 2008, arthritic episodes were becoming more difficult to successfully manage and higher doses and longer durations of treatment with carprofen were needed (2 mg/kg p.o. b.i.d.) and by August 2009 episodic treatment was no longer successful so the carprofen was continued indefinitely at 1 mg/kg p.o. s.i.d. In November 2009 carprofen was increased to 2 mg/kg p.o. b.i.d. An NMDA antagonist amantadine sulphate was trialed and after 10 days at 200 mg p.o. s.i.d. the clinical signs resolved. Since then it has been maintained on carprofen at 1 mg/kg p.o. b.i.d., amantadine sulphate 200 mg p.o. s.i.d. and the neutraceuticals as above with no further relapses of arthritic pain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.